Pediatrix Medical Group(NYSE) MD

Pediatrix provides specialized doctors for newborn babies and high-risk pregnancies. They help hospitals manage intensive care units for premature infants. The company also offers heart and surgical care for children.

Caring for the Tiniest Patients

• Neonatal Care: Medical services for premature or sick babies in hospital intensive care units; clinicians staff over 360 units across 32 states.
• Maternal-Fetal Care: Specialized inpatient and office-based treatment for expectant mothers and unborn babies during high-risk pregnancies.
• Pediatric Subspecialties: Hospital-based services including intensive care, surgery, and hospitalist management for acutely ill children.
• Hearing Screenings: National program that tested over 793,000 babies for potential hearing loss in 2025.
• Management Services: Administrative support for physician groups including billing, staffing, and recruiting; accounted for 14% of net revenue in 2025.

Strategic Shifts and Acquisitions

• Exited almost all office-based practices and the primary and urgent care service lines during 2024 to focus on core specialties.
• Acquired one maternal-fetal practice and several neonatology and hospitalist practices in a single 2025 transaction.
• Rebranded as Pediatrix Medical Group, Inc. in July 2022 to better reflect its clinical focus.
• Transformed the revenue cycle management function in 2024 to a hybrid model using internal personnel and third-party providers.

What Makes Pediatrix Stand Out

The company maintains a clinical data warehouse with information from more than 2.1 million patients to help doctors improve medical outcomes. Its nationwide network connects approximately 2,295 physicians across 37 states to provide coordinated hospital-based care.

A Look at the Numbers

• Net revenue reached $493.8 million in Q4 2025, down 1.7% from the previous year.
• Operating income grew to $54.7 million in Q4 2025, a 39.1% increase year-over-year.
• Net income was $33.7 million in Q4 2025, up 10.5% from Q4 2024.
• Free cash flow was $108.8 million in Q4 2025, a 16% decrease from the prior year.

The Final Word

Pediatrix has transitioned away from primary care to focus on specialized hospital services and maternal-fetal medicine. This strategic pivot uses its physician network and clinical data to drive operational performance.